
First US biosimilar is hung up in litigation with Amgen; meanwhile, Amgen and others form a Biosimilars Forum and FDA issues some final biosimilar guidance
First US biosimilar is hung up in litigation with Amgen; meanwhile, Amgen and others form a Biosimilars Forum and FDA issues some final biosimilar guidance
Combining high-quality patient-support services with comprehensive and continually updated analytics results in better outcomes
The growing number of certifications has become a competitive issue for SPPs bidding for Pharma's business
Meeting the compliance deadlines of the Drug Supply Chain Security Act has the attention of many in biopharma product and brand security
Streebo offers a free look at Sunshine Act data compiled by type, company and physician
IMS Institute report finds variations in access
General availability for applicants begins on June 3
As new cancer drugs with promising efficacy but brutal costs enter the market, providers, payers and manufacturers are strategizing new payment approaches
Heightened concern over adherence and product stability may win over more pharma clients
Meanwhile, industry asset shuffling is at record levels
Obama's Precision Medicines initiative could re-open the door
Use of state-of-the-art software, combined with benchmarking and active oversight, fills this gap
Novo Nordisk is tagged as the only 'high performer'
Sandoz is first on the market with the MS drug, currently worth around $3 billion in the US
Effect of the first full year of Obamacare was muted, although a record number of prescriptions were written
Company targets evolving regenerative medicine market
$4.8-billion deal follows UPS' failed effort in 2013
Partners with EHR vendor PointClickCare to access 10,000 senior-care facilities in North America
Leading copay-coupon provider expands its patient services with private equity help
Service closes the loop on managing specialty-pharmaceutical therapy regimens
Do you know your J codes?
AstraZeneca's Seroquel XR sample kit takes top honors
If the count of working sales reps is rising, who will those reps be able to visit?
$12.8-billion acquisition will bring 1 billion precriptions/year under one PBM's management
Creation of a holding company streamlines future acquisitions; focus is on specialty drug services
National association wins oversight for the valuable top-level domain (TLD), begins approving online pharmacies' use of it
Veeva OpenKey database service will provide a standardized quality level for global healthcare-provider reference data
Office will serve Shanghai and Suzhou life sciences clients